Wintrust Investments’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Wintrust Investments's EXAS Position: Q2 2021 in Review
Wintrust Investments sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 2,270 shares — an estimated $299K sold.
Wintrust Investments first reported a position in EXAS in Q1 2021 and held it in 1 quarter. The position peaked at $299K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.
- Wintrust Investments reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
- Wintrust Investments sold 2,270 Exact Sciences shares in Q2 2021, an estimated $299K.
- Wintrust Investments first reported a position in Exact Sciences in Q1 2021 and held it in 1 quarter.
- Wintrust Investments's Exact Sciences position peaked at $299K in Q1 2021.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.
Based on Wintrust Investments's 13F filing for Q2 2021, filed 10 Aug 2021.